Abdominal MR angiography performed using blood pool contrast agents: Comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer

American Journal of Roentgenology

Volumn 171, Issue 1, 1998, Pages 107-113

  Nolte Ernsting, Claus ^a   Adam, Gerhard ^a   Bücker, Arno ^a   Berges, Sven ^a   Bjørnerud, Atle ^b   Günther, Rolf W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; POLYMER; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; WIN 22181;

ABDOMINAL RADIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD POOL SCINTISCANNING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SWINE;

EID: 0031831264     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.1.9648772     Document Type: Article

References (32)

1. Fahlvik AK, Klaveness J, Stark DD. Iron oxides as MR imaging contrast agents. J Magn Reson Imaging 1993;3:187-194
2. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168:297-301
3. Weissleder R, Elizondo G, Stark DD, et al. The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR 1989; 152:175-180
4. Fahlvik AK, Holtz E, Leander P, Schrøder U, Klaveness J. Magnetic starch microspheres, efficacy and elimination: a new organ-specific contrast agent for magnetic resonance imaging. Invest Radiol 1990;25:113-120
5. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498
6. Guimaraes R, Clément O, Bittoun J, Carnot F, Frija G. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. AJR 1994;162:201-207
7. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519
8. Canet E, Revel D, Forrat R, et al. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. Magn Reson Imaging 1993;11:1139-1145
9. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493
10. Mergo PJ, Helmberger T, Nicolas Al, Ros PR. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR 1996;166:379-384
11. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR 1994;162:209-213
12. Benderbous S, Bonnemain B. Superparamagnetic nanoparticles as blood-pool contrast agents. Radiologe 1995;35(suppl 2):248-252
13. Stillman AE, Wilke N, Li D, Haacke EM, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 1996;20:51-55
14. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR 1996;166:73-77
15. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214
16. Kellar KE, Henrichs PM, Hollister R, Koenig SH, Eck J, Wie D. High relaxivity linear Gd(DTPA)-polymer conjugates: the role of hydrophobic interactions. Magn Reson Med 1997;38:712-716
17. Bengele HH, Palmacci S, Rogers J, Jung CW, Crenshaw J, Josephson L. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. Magn Reson Imaging 1994;12:433-442
18. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993;29:599-604
19. Pouliquen D, Perroud H, Calza F, Jallet P, Le-Jeune JJ. Investigation of the magnetic properties of iron oxide nanoparticles used as a contrast agent for MRI. Magn Reson Med 1992;24:75-84
20. Marchal G, Bosmans H, Van Hecke P, et al. MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. AJR 1990;155: 407-411
21. Marchal G, Michiels J, Bosmans H, Van Hecke P. Contrast-enhanced MRA of the brain. J Comput Assist Tomogr 1992;16:25-29
22. Runge VM, Kirsch JE, Lee C. Contrast-enhanced MR angiography. J Magn Reson Imaging 1993; 3:233-239
23. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-164
24. Van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991;9:313-321
25. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR 1996;166:971-981
26. Hatabu H, Gaa J, Kim D, Wei L, Prasad PV, Edelman RR. Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. AJR 1996; 167:653-655
27. Steiner P, McKinnon GC, Romanowski B, Goehde SC, Hany T, Debatin JF. Contrast-enhanced, ultrafast 3D pulmonary MR angiography in a single breath-hold: initial assessment of imaging performance. J Magn Reson Imaging 1997;7:177-182
28. Stehling MK, Holzknecht N, Gauger J, et al. Gadolinium-enhanced magnetic resonance angiography with ultra-short echo times: initial experience. Radiologe 1996;36:670-675
29. Hany TF, Pfammatter T, Schmidt M, Leung DA, Debatin JF. Ultrafast contrast-enhanced 3D MR angiography of the aorta and renal arteries in apnea. Fortschr Röntgenstr 1997;166:397-405
30. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792
31. Prince MR, Chenevert TL, Foo TKF, Londy FJ, Ward JS, Maki JH. Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 1997;203: 109-114
32. Rofsky NM, Purdy DE, Johnson G, et al. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine. Radiology 1997; 202:177-182